文献速递临床试验与 GCP

慢性硬膜下血肿伴轻微症状患者的血管内治疗与保守治疗比较:多中心随机对照试验研究方案(EMBOTRIAL-1)

Endovascular vs conservative treatment in patients with chronic subdural hematomas and mild symptoms: a study protocol for a multicenter randomized controlled trial (EMBOTRIAL-1).
PubMed 文献 · Trials · 2025-11-18

本研究为意大利多中心前瞻性随机对照试验,采用开放标签治疗与盲法结局评估(PROBE设计),计划纳入300例慢性硬膜下血肿伴轻微症状患者,按1:1随机接受脑膜中动脉栓塞(干预组)或保守治疗(对照组)。主要结局为治疗失败,定义为6个月随访内血肿不完全吸收或需手术挽救的复合终点。

要点

  • 慢性硬膜下血肿缺乏明确指南,临床管理策略差异大,保守治疗多用于无症状或轻微症状伴轻度占位效应者。
  • 多项队列研究提示脑膜中动脉栓塞可能降低血肿复发和进展率,但需随机对照试验验证其有效性与安全性。
  • 本试验主要结局为6个月随访内血肿不完全吸收或手术挽救的复合终点,双侧血肿时任一血肿满足标准即判定治疗失败。

核心结论

  • 本多中心随机对照试验旨在评估脑膜中动脉栓塞促进血肿吸收和预防手术挽救的获益风险比;若栓塞优于保守治疗,可能推动进一步确证试验并改变临床实践和指南推荐。

研究设计与样本

  • 意大利多中心前瞻性随机对照试验,采用开放标签治疗与盲法结局评估(PROBE设计),计划随机300例患者按1:1分配至脑膜中动脉栓塞组或保守治疗组。

主要发现

  • 主要结局为治疗失败,定义为6个月随访内血肿不完全吸收或手术挽救的复合终点。
  • 血肿不完全吸收定义为随访时血肿厚度较随机化时测量值减少≤50%。
  • 手术挽救定义为因症状缓解或血肿持续增长出现的症状而行血肿清除。
  • 双侧慢性硬膜下血肿时,任一血肿满足主要结局标准即判定治疗失败。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic subdural hematoma (cSDH) is a common neurosurgical condition that is prevalent in elderly patients. There are no well-defined guidelines for cSDH and management strategies vary widely among physicians and institutions, and this variability is expressed in the literature. In general, conservative management is reserved to patients who are asymptomatic or have minor symptoms with mild mass effect. Spontaneous resolution of cSDH is an unusual phenomenon and middle meningeal artery (MMA) embolization seems to reduce the recurrence and progression rate of SDH compared to conventional treatments in multiple cohort studies. A randomized controlled trial is warranted to determine the effectiveness and safety of endovascular embolization for cSDH and whether MMA embolization is superior to conservative management in reducing the progression rate and surgical rescue event. METHODS: This is an Italian multicenter prospective randomized clinical trial with open-label treatment and blinded outcome assessment (PROBE design) to assess the superiority of MMA embolization compared to conservative treatment. A total of 300 patients are planned to be randomized 1:1 to receive MMA embolization (intervention) or conventional treatments (control). The primary outcome is the treatment arm failure which is defined as a composite of incomplete hematoma resolution or surgical rescue within 6 months follow-up. Incomplete hematoma resolution is defined as a reduction of the cSDH thickness ≤50% at follow-up compared to the hematoma thickness measured at the time of randomization. Surgical rescue is intended as hematoma removal for relief or symptoms that developed with continuous growth of the cSDH. In case of bilateral cSDH, the treatment failure occurred when primary outcomes criteria are satisfied for at least one of the two hematomas. DISCUSSION: This multi-centre randomized controlled trial is needed to evaluate the benefit-to-risk ratio of primary embolization of the MMA to facilitate resolution and prevent rescue surgical evacuation of cSDH. If MMA embolization turns out to be superior to conservative management in this trial, this may prompt further confirmatory trials and, at best, may change clinical practice and guideline recommendations. TRIAL REGISTRATION: ClinicalTrials.gov. Identifier: NCT06274580, Registered on 6 February 2024. This protocol was developed in accordance with the SPIRIT Checklist and by use of the structured study protocol template provided by BMC Trials.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Salsano G, Fiaschi P, Laura G, et al. Endovascular vs conservative treatment in patients with chronic subdural hematomas and mild symptoms: a study protocol for a multicenter randomized controlled trial (EMBOTRIAL-1). Trials. 2025. PMID: 41254694. doi:10.1186/s13063-025-09131-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。